Investors didn't like what they heard during the Canadian cannabis producer's announcement on Friday.
News & Analysis: OrganiGram Holdings
Will the potential of cannabis derivatives products push these two cannabis companies towards growth this year?
Which pot stock wins in a matchup between these two U.S. and Canadian cannabis leaders?
A new class-action lawsuit is a buzz kill for the two Canadian peers.
A rising tide is lifting most boats.
The deal with medical marijuana company Canndoc could also help the OrganiGram reach other international markets.
Which of these two Canadian pot producers should you invest in today?
Could this be the next industry to rebound?
They can blame a high-profile peer in their sector.
The cannabis company is making some new goodies available to medical marijuana users.